QID 981483

QID 981483: Nodejs (npm) Security Update for websocket-extensions (GHSA-g78m-2chm-r7qv)

Security update has been released for websocket-extensions to fix the vulnerability.

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

The ReDoS flaw allows an attacker to exhaust the server's capacity to process
incoming requests by sending a WebSocket handshake request containing a header
of the following form:

Sec-WebSocket-Extensions: a; b="\c\c\c\c\c\c\c\c\c\c ...

That is, a header containing an unclosed string parameter value whose content is
a repeating two-byte sequence of a backslash and some other character. The
parser takes exponential time to reject this header as invalid, and this will
block the processing of any other work on the same thread. Thus if you are
running a single-threaded server, such a request can render your service
completely unavailable.

CVSS V3 rated as High - 7.5 severity.

CVSS V2 rated as Medium - 5 severity.

Solution

Users should upgrade to version 0.1.4.Workaround:
There are no known work-arounds other than disabling any public-facing
WebSocket functionality you are operating.

Vendor References

GHSA-g78m-2chm-r7qv - github.com/advisories/GHSA-g78m-2chm-r7qv

CVEs related to QID 981483

CVE-2020-7662 |

Software Advisories

Advisory ID	Software	Component	Link
GHSA-g78m-2chm-r7qv	websocket-extensions		github.com/advisories/GHSA-g78m-2chm-r7qv

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].